Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
covid-19
9
×
fda
9
×
coronavirus
biotech
boston blog main
clinical trials
life sciences
national blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
gear
indiana blog main
indiana top stories
medicine
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
vir biotechnology
wisconsin blog main
wisconsin top stories
What
covid
fda
new
bio
coronavirus
roundup
treat
cancer
day
days
emergency
ipo
medical
abbvie’s
acquisitions
ahead
alliance
announced
antibodies
antibody
approval
assistant
attempt
authorized
bamlanivimab
battle
biofourmis
biotech
block
boost
breakthrough
bristol
bucks
buy
calls
cases
celebrate
center
ceo
chance
Language
unset
9
×
Current search:
covid-19
×
fda
×
unset
×
@engadget.com
3 years ago
FDA clears emergency use of lab-made antibodies to treat COVID-19
@bgr.com
3 years ago
FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
@bgr.com
3 years ago
FDA warns that this at-home coronavirus therapy that could do more harm than good
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@engadget.com
3 years ago
Telehealth got a huge boost from COVID-19. Now what?
@engadget.com
3 years ago
Fitbit's COVID-19 ventilator gets emergency FDA approval
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More